Cristina Mayor-Ruiz obtained her PhD in 2017 under the supervision of Dr. Fernández-Capetillo at the CNIO (Madrid), where she unraveled novel mechanisms of resistance to anticancer therapies. In 2018, she joined the group of G. Winter (CeMM, Vienna) for her postdoc and innovated chemical biology approaches in the field of targeted protein degradation. Since 2021, she is a Junior Group Leader at the IRB Barcelona. At the interface of chemical biology and cancer research, her team focuses on developing proximity-inducing pharmacology with therapeutic interest (e.g., molecular glues, PROTACs, etc.) and tackling biological questions around E3 ubiquitin ligases. Dr. Mayor-Ruiz has been honored with national and international awards, such as an ERC Starting grant.